Cc1cc(NS(=O)(=O)c2ccc(/N=N/c3c(O)c(C(=O)O)cc4ccccc34)cc2)nc(C)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?